We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > BGV

News List

Lonza, Forbion and BioGeneration Ventures Extend Collaboration contractpharma
January 18, 2022
To add development and manufacturing services of small molecules.
BioGeneration Ventures Closes BGV IV Fund at €105 Million B3C newswire
July 01, 2020
BioGeneration Ventures (BGV), a leading early-stage VC in European biopharma, announces the closing of its fourth fund, BGV IV, at €105 million ($119 million). Strong market interest expediated the fund raise, with the commitments to date exceeding the fu
BioGeneration Ventures Fund III Reaches EUR 82 Million in Final Close .b3cnewswire
April 23, 2019
Investments from Bristol-Myers Squibb and Johnson & Johnson Innovation - JJDC.
BioGeneration Ventures Fund III Secures EUR 66m, Exceeding EUR 50m Target b3cnewswire
June 27, 2017
BioGeneration Ventures Fund III Secures EUR 66m, Exceeding EUR 50m Target